Standardized questionnaires
An interface for established instruments on pain and quality of life in hemophilia, e.g. the Haemo-QoL.
smart medication EmiQoL
Pain and quality of life in view
smart medication EmiQoL is a study tool with which hemophilia treatment centers capture their patients’ pain and quality of life in a structured way: standardized questionnaires such as the Haemo-QoL are answered on a tablet – in the waiting room, during the consultation or at the study visit – and are immediately available to the care team for evaluation.
At a glance
- Target group
- Hemophilia treatment centers and study teams
- Instruments
- Standardized questionnaires on pain and quality of life in hemophilia, e.g. the Haemo-QoL
- Platform
- Tablet application
- Settings
- Waiting room, consultation, study visit
- Result
- Answers are immediately available in structured, analyzable form – no paper, no transcription errors
- Data protection
- GDPR-compliant, data stored on our own servers in Germany
- Support
- Developed and operated by smart medication, supported by Chugai Pharma; data collection and analysis are manufacturer- and product-independent
How are patients really doing with their therapy? Bleeds and injections can be counted – pain and quality of life cannot. That is exactly what smart medication EmiQoL is for: a study tool that makes both capturable in a structured way.
EmiQoL brings standardized questionnaires – such as the Haemo-QoL – to the patient as a tablet application: in the waiting room, in the consultation, or at the study visit. The answers are immediately available to the care team in structured form – without paper and without transcription errors.
What EmiQoL delivers
Tablet instead of paper
Patients answer the questionnaires directly on the tablet – with no switch between media and no retyping afterwards.
Structured results
The answers are immediately available for analysis – for the course of treatment as well as for studies.
For studies and routine care
Patient-Reported Outcomes are gaining weight in clinical studies and in health services research: increasingly, what counts is not only how well a therapy works, but also how it affects everyday life. EmiQoL makes this perspective systematically capturable.
As with all smart medication applications: processing is GDPR-compliant, with data kept on our own servers in Germany.
Developed by smart medication, supported by Chugai
EmiQoL was developed by smart medication and is operated by us. The application is supported by Chugai Pharma. Data collection and analysis themselves are independent of any manufacturer or product.
EmiQoL for your study or your center?
Are you planning a study, or would you like to capture pain and quality of life in a structured way at your center? Get in touch – we will gladly show you EmiQoL in action.
Frequently asked questions
Which questionnaires does EmiQoL support?
Standardized, established instruments on pain and quality of life in hemophilia – for example the Haemo-QoL. EmiQoL is the interface that brings such questionnaires to the patient as a tablet application.
Is EmiQoL intended for studies or for routine care?
For both. Patient-reported outcomes are gaining weight in clinical studies and in health services research; EmiQoL makes them systematically measurable – at the study visit as well as during the consultation for the course of treatment.
Where are the collected data stored?
As with all smart medication applications: GDPR-compliant processing, data stored on our own servers in Germany.
Is EmiQoL tied to Chugai?
No. EmiQoL was developed by smart medication and is operated by us; Chugai Pharma supports the application. Data collection and analysis are manufacturer- and product-independent.